Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
21.44
-0.19 (-0.88%)
At close: Aug 17, 2026, 4:00 PM EDT
24.70
+3.26 (15.21%)
After-hours: Aug 17, 2026, 4:12 PM EDT
Amylyx Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $24 → $30 | Buy | Reiterates | $24 → $30 | +39.93% | Aug 17, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $19 → $28 | Buy | Maintains | $19 → $28 | +30.60% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $34 | Buy | Maintains | $34 | +58.58% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $22 → $30 | Buy | Reiterates | $22 → $30 | +39.93% | Aug 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $24 | Buy | Maintains | $24 | +11.94% | Aug 6, 2026 |
| Citi | Citi | Buy Maintains $20 → $26 | Buy | Maintains | $20 → $26 | +21.27% | Aug 3, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $40 | Buy | Reiterates | $40 | +86.57% | Jun 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.